Search research articles
Contact Us
Filters
Showing results (61-70 of 147) with videos related to
Page
of 15
Sort By:
Minerva Cardiology and Angiology
|
October 23, 2023
Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy
Salvatore Giordano, Francesco Franchi, Fabiana Rollini, et al.
Expert Review of Clinical Pharmacology
|
July 11, 2017
Role of genetic testing in patients undergoing percutaneous coronary intervention
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
International Journal of Cardiology
|
May 8, 2012
Effect of cardiac resynchronization therapy on left atrial reverse remodeling: role of echocardiographic AV delay optimization
Alessandro Malagoli, Luca Rossi, Francesco Franchi, et al.
Expert Review of Cardiovascular Therapy
|
November 3, 2023
Bivalirudin in acute coronary syndromes
Mattia Galli, Marco Bernardi, Luis Ortega-Paz, et al.
Drugs
|
July 29, 2024
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
Mattia Galli, Giovanni Occhipinti, Luis Ortega-Paz, et al.
Journal of the American College of Cardiology
|
February 13, 2016
Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI
Dominick J Angiolillo, Francesco Franchi, Ron Waksman, et al.
Thrombosis and Haemostasis
|
October 10, 2025
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies
Luis Ortega-Paz, Yasushi Ueki, Claudio Laudani, et al.
Expert Review of Clinical Pharmacology
|
December 1, 2022
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications
Mattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Minerva Cardiology and Angiology
|
November 11, 2021
Dual pathway inhibition in atherothrombosis prevention: yes, now we can!
Francesco Summaria, Giuseppe Biondi-Zoccai, Enrico Romagnoli, et al.
JACC. Cardiovascular Interventions
|
July 8, 2017
In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y<sub>12</sub> Receptor-Mediated Signaling in Ticagrelor-Treated Patients
Fabiana Rollini, Francesco Franchi, Estela Thano, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 147) with videos related to
Sort By:
Page
of 15
Minerva Cardiology and Angiology
|
October 23, 2023
Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy
Salvatore Giordano, Francesco Franchi, Fabiana Rollini, et al.
Expert Review of Clinical Pharmacology
|
July 11, 2017
Role of genetic testing in patients undergoing percutaneous coronary intervention
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
International Journal of Cardiology
|
May 8, 2012
Effect of cardiac resynchronization therapy on left atrial reverse remodeling: role of echocardiographic AV delay optimization
Alessandro Malagoli, Luca Rossi, Francesco Franchi, et al.
Expert Review of Cardiovascular Therapy
|
November 3, 2023
Bivalirudin in acute coronary syndromes
Mattia Galli, Marco Bernardi, Luis Ortega-Paz, et al.
Drugs
|
July 29, 2024
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
Mattia Galli, Giovanni Occhipinti, Luis Ortega-Paz, et al.
Journal of the American College of Cardiology
|
February 13, 2016
Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI
Dominick J Angiolillo, Francesco Franchi, Ron Waksman, et al.
Thrombosis and Haemostasis
|
October 10, 2025
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies
Luis Ortega-Paz, Yasushi Ueki, Claudio Laudani, et al.
Expert Review of Clinical Pharmacology
|
December 1, 2022
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications
Mattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Minerva Cardiology and Angiology
|
November 11, 2021
Dual pathway inhibition in atherothrombosis prevention: yes, now we can!
Francesco Summaria, Giuseppe Biondi-Zoccai, Enrico Romagnoli, et al.
JACC. Cardiovascular Interventions
|
July 8, 2017
In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y<sub>12</sub> Receptor-Mediated Signaling in Ticagrelor-Treated Patients
Fabiana Rollini, Francesco Franchi, Estela Thano, et al.
Page
of 15